Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 10, 2014
Technology Networks
 
Register | Sign in
Home Page
  News
Return

Study Shows Potential of Differentiated iPS Cells in Cell Therapy without Immune Rejection

Published: Wednesday, January 30, 2013
Last Updated: Wednesday, January 30, 2013
Bookmark and Share
Boston University School of Medicine study shows that tissues derived from iPS cells in an experimental model were not rejected when transplanted back into genetically identical recipients.


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here


Scientific News
Researchers Regrow Human Corneas
Limbal stem cells - identified with a new marker - could reverse a leading cause of blindness.
New Reprogramming Method Makes Better Stem Cells
Researchers have shown for the first time that stem cells created using different methods produce differing cells.
Scientists Identify Link Between Stem Cell Regulation and the Development of Lung Cancer
Study explains how factors that regulate the growth of adult stem cells lead to the formation of precancerous lesions.
CRI Finds Key to Identifying, Enriching Mesenchymal Stem Cells
Biomarker enables researchers to accurately characterize the properties and function of MSCs in the body.
Researchers Find Gene Critical for Development of Brain Motor Centre
The team describes the Snf2h gene, which is found in our brain's neural stem cells and functions as a master regulator.
Stem Cells Form Light-Sensitive 3-D Retinal Tissue
Researchers induced human stem cells to create a 3-D retina structure that responds to light. The finding may aid the study of eye diseases and could eventually lead to new therapies.
Genetic Pathway for Chronic Kidney Disease Revealed
Findings from the study open the door to early treatment for millions at risk for CKD.
New Approach to Accelerate Dementia Research
The Medical Research Council has launched the UK Dementias Research Platform, a £16 M public-private partnership set up to speed up research into dementias.
Can Regenerative Medicine be the Cure for Cancer and Other Deadly Diseases?
Change in regulatory frameworks and standards are essential to expedite approval and release of innovative products.
New Developments in Big, Open Access Data for Dementia
Prime Minister, David Cameron, pledged a UK commitment to discover new drugs and treatment that could slow down the on-set of dementia or even deliver a cure by 2025.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv